Received: 20 September 2017
Accepted: 15 March 2018
First Online: 23 March 2018
Ethics approval and consent to participate
: The local Medical Ethical Committee approved this study and written informed consent was obtained from all participants included in this study.
: Not applicable.
: Emma M. Coppen and Jeroen van der Grond report no competing interest. Raymund A.C. Roos receives grants from TEVA Pharmaceuticals, Cure Huntington’s Disease Initiative (CHDI), Gossweiler Foundation, and is member of the advisory board of UniQure.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.